0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Prostate Cancer
 41-60 of 80 Articles
Invited Commentary | 
Richard M. Hoffman, MD, MPH; Steven B. Zeliadt, PhD
Arch Intern Med. 2010;170(14):1262-1263. doi:10.1001/archinternmed.2010.222.

Original Investigation |  FREE
Yu-Hsuan Shao, PhD; Peter C. Albertsen, MD; Calpurnyia B. Roberts, PhD; et al.
Arch Intern Med. 2010;170(14):1256-1261. doi:10.1001/archinternmed.2010.221.

Invited Commentary | 
Michael J. Barry, MD
Arch Intern Med. 2010;170(5):450-452. doi:10.1001/archinternmed.2010.2.

Original Investigation |  FREE
Thomas L. Jang, MD, MPH; Justin E. Bekelman, MD; Yihai Liu, MS; et al.
Arch Intern Med. 2010;170(5):440-450. doi:10.1001/archinternmed.2010.1.

Original Investigation |  FREE
Kirsten Howard, BSc(Hons), MAppSc, MPH, MHealthEcon, PhD; Alex Barratt, MBBS, MPH, PhD; Graham J. Mann, MBBS, PhD; et al.
Arch Intern Med. 2009;169(17):1603-1610. doi:10.1001/archinternmed.2009.282.

Original Investigation |  FREE
Richard M. Hoffman, MD, MPH; Mick P. Couper, PhD; Brian J. Zikmund-Fisher, PhD; et al.
Arch Intern Med. 2009;169(17):1611-1618. doi:10.1001/archinternmed.2009.262.

Editorial | 
Michael Pignone, MD, MPH
Arch Intern Med. 2009;169(17):1554-1556. doi:10.1001/archinternmed.2009.269.

Editorial | 
Steven H. Woolf, MD, MPH; Alex Krist, MD, MPH
Arch Intern Med. 2009;169(17):1557-1559. doi:10.1001/archinternmed.2009.291.

Editor's Correspondence | 
Arch Intern Med. 2008;168(18):2046-2047. doi:10.1001/archinte.168.18.2046-b.

Original Investigation |  FREE
Mukaila A. Raji, MD, MSc; Yong-Fang Kuo, PhD; Jean L. Freeman, PhD; et al.
Arch Intern Med. 2008;168(18):2033-2040. doi:10.1001/archinte.168.18.2033.

Editor's Correspondence | 
Mack Roach III, MD
Arch Intern Med. 2008;168(12):1351. doi:10.1001/archinte.168.12.1351.

Editor's Correspondence | 
Jarrod B. Adkison, MD; Mark A. Ritter, MD, PhD
Arch Intern Med. 2008;168(12):1352. doi:10.1001/archinte.168.12.1352-a.

Editor's Correspondence | 
Karl Mikael Kälkner, MD, PhD
Arch Intern Med. 2008;168(12):1352-1353. doi:10.1001/archinte.168.12.1352-b.

Editor's Correspondence | 
Elisabetta Rapiti, MD, MPH; Arnaud Merglen, MD; Christine Bouchardy, MD, MPH
Arch Intern Med. 2008;168(12):1353. doi:10.1001/archinte.168.12.1353.

Original Investigation |  FREE
Dominick L. Frosch, PhD; Vibha Bhatnagar, MD, MPH; Steven Tally, PhD; et al.
Arch Intern Med. 2008;168(4):363-369. doi:10.1001/archinternmed.2007.111.

Research Letters |  FREE
Shahrokh F. Shariat, MD; Dolores J. Lamb, PhD; Claus G. Roehrborn, MD; et al.
Arch Intern Med. 2008;168(2):235-236. doi:10.1001/archinternmed.2007.34.

Editor's Correspondence | 
Giuseppe Lippi, MD; Martina Montagnana, MD; Gian Cesare Guidi, MD
Arch Intern Med. 2007;167(22):2529-2530. doi:10.1001/archinte.167.22.2529.

Original Investigation |  FREE
Wildon R. Farwell, MD, MPH; Jeffrey A. Linder, MD, MPH; Ashish K. Jha, MD, MPH
Arch Intern Med. 2007;167(22):2497-2502. doi:10.1001/archinte.167.22.2497.

Original Investigation |  FREE
Arnaud Merglen, MD; Franz Schmidlin, MD; Gerald Fioretta, BSc; et al.
Arch Intern Med. 2007;167(18):1944-1950. doi:10.1001/archinte.167.18.1944.

Original Investigation |  FREE
B. Price Kerfoot, MD, EdM; Erika F. Holmberg, MPH; Elizabeth V. Lawler, MPH, ScD; et al.
Arch Intern Med. 2007;167(13):1367-1372. doi:10.1001/archinte.167.13.1367.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Research Letter  | 
Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States A Nationwide Survey Analysis
Firas Abdollah, MD; Maxine Sun, MPH; Jesse D. Sammon, DO; et al.
JAMA Oncology
Original Investigation  | 
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both The TRAPEZE Randomized Clinical Trial
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncology
Invited Commentary  | 
DNA Damage and Repair Pathway Profiles as Biomarkers in High-Risk Prostate Cancer
Sean E. McGuire, MD, PhD
JAMA Oncology
Invited Commentary  | 
Targeted Cancer Screening After Solid-Organ Transplantation
Marianne Schmid, MD; Felix K.-H. Chun, MD; Quoc-Dien Trinh, MD